Anti-phospholipid autoantibodies in human diseases

R Qin, H Wu, H Guan, C Tang, Z Zheng, C Deng… - Clinical …, 2023 - Elsevier
Anti-phospholipid autoantibodies are a group of antibodies that can specifically bind to
anionic phospholipids and phospholipid protein complexes. Recent studies have reported …

Spontaneous power generation from broad-humidity atmospheres through heterostructured F/O-bonded graphene monoliths

K Fan, X Liu, Y Liu, Y Li, X Liu, W Feng, X Wang - Nano Energy, 2022 - Elsevier
Spontaneous energy-harvesting from the environment without external stimuli is a
challenging task for clean and renewable power. However, existing carbon-based energy …

[HTML][HTML] Domain 5 of Beta 2 glycoprotein I: Friend or foe in health? Context matters

B Giannakopoulos, SA Krilis - Clinical Immunology, 2024 - Elsevier
Abstract Beta 2 glycoprotein I (B2GPI) is the major autoantigen in the antiphospholipid
syndrome, an autoimmune disorder characterized by thrombotic and obstetric complications …

In silico identification of new inhibitors for βeta-2-glycoprotein I as a major antigen in antiphospholipid antibody syndrome

S Mahdian, M Zarrabi, A Moini, M Movahedi… - Journal of Molecular …, 2020 - Springer
Beta 2 glycoprotein I (β2GPI) is a major antigen for autoantibodies present in
antiphospholipid antibody syndrome (APS). β2GPI is a single polypeptide with five repeated …

In vivo evidence of angiogenesis inhibition by β2-glycoprotein I subfractions in the chorioallantoic membrane of chicken embryos

CM Baldavira, LF Gomes, LTDL Cruz… - Brazilian journal of …, 2021 - SciELO Brasil
The vascular network expansion and functioning are important factors affecting normal intra-
uterine fetal development. This study addressed the previously reported antiangiogenic …